Renalytix
Stock Forecast, Prediction & Price Target
Renalytix Financial Estimates
Renalytix Revenue Estimates
Renalytix EBITDA Estimates
Renalytix Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2026 | 6/30/2027 | ||
Revenue
% change YoY
| $2.97M N/A | $3.40M 14.57% | $2.28M -32.73% | Avg: $50.42M Low: $38.75M High: $62.13M avg. 2102.84% | Avg: $114.3M Low: $87.84M High: $140.85M avg. 126.68% | ||
Net Income
% change YoY
| $-56.73M N/A | $-45.60M 19.60% | $-33.45M 26.64% | Avg: $-14.32M Low: $-18.64M High: $-10.01M avg. 57.19% | Avg: $19.73M Low: $13.79M High: $25.68M avg. 237.76% | ||
EBITDA
% change YoY
| $-45.11M N/A | $-41.71M 7.53% | $-28.52M 31.62% | Avg: $-10.08M Low: $-12.42M High: $-7.75M avg. 64.64% | Avg: $-22.85M Low: $-28.17M High: $-17.56M avg. -126.68% | ||
EPS
% change YoY
| -$1.56 N/A | -$0.55 64.74% | -$0.31 43.63% | Avg: -$0.35 Low: -$0.45 High: -$0.24 avg. -12.39% | Avg: $0.48 Low: $0.34 High: $0.62 avg. 237.76% | ||
Operating Expenses
% change YoY
| $58.29M N/A | $43.05M -26.13% | $29.04M -32.55% | Avg: $248.37M Low: $190.89M High: $306.08M avg. 755.26% | Avg: $563.02M Low: $432.71M High: $693.83M avg. 126.68% | ||
FAQ
What is Renalytix stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 147.47% in 2026-2027.
We have gathered data from N/A analysts. Their low estimate is -18.64M, average is -14.32M and high is -10.01M.
What is Renalytix stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1114.76% in 2026-2027.
We have gathered data from N/A analysts. Their low revenue estimate is $38.75M, average is $50.42M and high is $62.13M.
What is Renalytix stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 112.68% in 2026-2027.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.45, average is -$0.35 and high is $-0.24.
What is the best performing analyst?
In the last twelve months analysts have been covering Renalytix stock. The most successful analyst is Mark Massaro.